Issuer: CureVac / Key word: Quarter Results
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
23.05.2024 / 13:00.
Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine
CureVac Announces Financial Results for the First Quarter of 2024 and pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Operator: Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.